Patients Suffer Due to Institutional Corruption in the Pharmaceutical Industry

By: Jeffrey D. DeCarlo, P.A.

Almost every day, there is a new story about a drug that had a dangerous or unexpected side effect and that is causing serious illness or injury to patients. Many may wonder how this keeps happening when the Food and Drug Administration is supposed to protect the public from dangerous drugs and when the pharmaceutical manufacturers have an obligation to make sure that their products are tested and safe before those drugs are sold. golden-pill-1245005-m

A recent article in the Journal of Law, Medicine and Ethics sheds some potential light on how and why pharmaceutical companies keep releasing products that cause so much damage. The proposed answer is institutional corruption, which runs deep at multiple levels. Institutional corruption isn’t any particular rule violation or broken law, but instead as states it refers to “a certain kind of influence, within an economy if influence has a certain effect.” An experienced dangerous drug lawyer in Miami knows that there is plenty of reason to believe that institutional corruption exists on several levels within big pharma, and the recent journal article helps to illustrate the extent of the problem.


About Law Wire News

At Law Wire News we write and publish original and syndicated news and press releases related to the law.
This entry was posted in Personal Injury Lawyer and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s